Results 191 to 200 of about 565,751 (376)
Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology
What's New? Preeclampsia is protective against breast cancer, but it is not clear if the effect extends to all breast tumors. This study examined the association between preeclampsia and breast tumor histology. The findings suggest that the protective effect of preeclampsia is concentrated among ductal and lobular tumors, but not other tumors. Patients
Shu Qin Wei+8 more
wiley +1 more source
Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters. [PDF]
Xiao Y, Linghu H.
europepmc +1 more source
What's New? Neoadjuvant chemotherapy (NACT) can be highly effective for patients with early‐stage breast cancer. Patients with hormone receptor‐positive (HRpos), HER2‐negative (HER2neg) breast cancer, however, may benefit less from NACT. Here, the authors investigated survival outcomes with adjuvant chemotherapy or NACT in a population of ...
Milena Beierlein+43 more
wiley +1 more source
The Controversies and Challenges in the Management of Twin Pregnancy: From the Perspective of International Federation of Gynecology and Obstetrics Guidelines. [PDF]
Liu J, Liu Q, Zhao J, Li D, Zhou Y.
europepmc +1 more source
Abstract To determine the prevalence of postpartum depression (PPD) and postpartum stress (PPS) and identify associated risk factors among mothers of preterm and low birth weight (LBW) infants. We conducted a secondary analysis of data collected from 255 mothers with preterm and LBW infants admitted to the neonatal intensive care unit (NICU) at Korle ...
John Pellegrino+6 more
wiley +1 more source
Biomedical ethical analysis of patients' perspectives on posthumous reproduction in a gynecology and obstetrics clinic. [PDF]
Köken AH, Kara Ö, İnce N, Kara M.
europepmc +1 more source
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial. [PDF]
Hu Y+35 more
europepmc +1 more source